Myocardial uptake of 68Ga-DOTATATE: correlation with cardiac disease and risk factors

被引:5
作者
Itani, Malak [1 ]
Haq, Adeel [1 ]
Amin, Manik [2 ]
Mhlanga, Joyce [1 ]
Lenihan, Daniel [3 ]
Iravani, Amir [1 ]
Trikalinos, Nikolaos A. [4 ]
机构
[1] Washington Univ, Mallinckrodt Inst Radiol, St Louis, MO 63110 USA
[2] Dartmouth Hitchcock Med Ctr, Dept Med Oncol, Lebanon, NH 03766 USA
[3] Washington Univ, Sch Med, Cardiooncol Ctr Excellence, Div Cardiol, St Louis, MO 63110 USA
[4] Washington Univ, Dept Med, St Louis, MO 63110 USA
关键词
Ga-68-DOTATATE; somatostatin receptor; positron emission tomography; cardiac disease; coronary artery disease; coronary calcifications; INFLAMMATION; PET/CT;
D O I
10.1177/02841851211054193
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background Myocardial uptake on Ga-68-DOTATATE PET/CT is often observed and its clinical relevance is poorly understood. Purpose To detect any correlation between myocardial uptake of Ga-68-DOTATATE and presence of cardiac disease or risk factors. Material and Methods In this institutional review board-approved retrospective study, we reviewed Ga-68-DOTATATE PET/CT scans in our institution between 1 May 2018 and 30 September 2018. A semi-quantitative score (MUS) for myocardial uptake of Ga-68-DOTATATE was developed by measuring mean standardized uptake value (SUV) in five myocardial regions, corrected by blood pool activity, and MUS was validated between two readers. We investigated the relationship between MUS and presence of cardiac disease or risk factors, including Framingham score and coronary calcification. Results A total of 145 scans were included (79 women; mean age = 56.9 +/- 13.7 years). Inter-reader agreement was excellent with intraclass correlation coefficient (r) = 0.964 (95% confidence interval [CI] = 0.903-0.987; P < 0.001). There was a weak but significant positive correlation between MUS and presence of coronary calcifications (Spearman rho = 0.20; P = 0.016). MUS was higher in patients with heart disease or risk factors (n = 83, mean MUS 2.03, 95% CI = 1.85-2.21) compared to those without (n = 23, mean MUS 1.40, 95% CI = 1.17-1.62; P < 0.001), although the cardiac disease group was older with a higher percentage of men (62.0 years, 57.8% men compared to 47.6 years, 13.0% men; P value <0.0001 for both comparisons). Conclusion For patients undergoing Ga-68-DOTATATE PET/CT scan, an elevated MUS might indicate an underlying heart disease.
引用
收藏
页码:1166 / 1172
页数:7
相关论文
共 17 条
[1]   Long-Acting Somatostatin Analog Therapy Differentially Alters 68Ga-DOTATATE Uptake in Normal Tissues Compared with Primary Tumors and Metastatic Lesions [J].
Ayati, Narjess ;
Lee, Sze Ting ;
Zakavi, Rasoul ;
Pathmaraj, Kunthi ;
Al-Qatawna, Louai ;
Poon, Aurora ;
Scott, Andrew M. .
JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (02) :223-227
[2]   Features of Carcinoid Heart Disease Identified by 2-and 3-Dimensional Echocardiography and Cardiac MRI [J].
Bhattacharyya, Sanjeev ;
Toumpanakis, Christos ;
Burke, Margaret ;
Taylor, Andrew M. ;
Caplin, Martyn E. ;
Davar, Joseph .
CIRCULATION-CARDIOVASCULAR IMAGING, 2010, 3 (01) :103-111
[3]   Feasibility of somatostatin receptor-targeted imaging for detection of myocardial inflammation: A pilot study [J].
Bravo, Paco E. ;
Bajaj, Navkaranbir ;
Padera, Robert F. ;
Morgan, Victoria ;
Hainer, Jon ;
Bibbo, Courtney F. ;
Harrington, Meagan ;
Park, Mi-Ae ;
Hyun, Hyewon ;
Robertson, Matthew ;
Lakdawala, Neal K. ;
Groarke, John ;
Stewart, Garrick C. ;
Dorbala, Sharmila ;
Blankstein, Ron ;
Di Carli, Marcelo F. .
JOURNAL OF NUCLEAR CARDIOLOGY, 2021, 28 (03) :1089-1099
[4]   Gastroenteropancreatic Neuroendocrine Tumors [J].
Cives, Mauro ;
Strosberg, Jonathan R. .
CA-A CANCER JOURNAL FOR CLINICIANS, 2018, 68 (06) :471-487
[5]   General cardiovascular risk profile for use in primary care - The Framingham Heart Study [J].
D'Agostino, Ralph B. ;
Vasan, Ramachandran S. ;
Pencina, Michael J. ;
Wolf, Philip A. ;
Cobain, Mark ;
Massaro, Joseph M. ;
Kannel, William B. .
CIRCULATION, 2008, 117 (06) :743-753
[6]   Serotonin and the heart [J].
Frishman, WH ;
Grewall, P .
ANNALS OF MEDICINE, 2000, 32 (03) :195-209
[7]   Appropriate Use Criteria for Somatostatin Receptor PET Imaging in Neuroendocrine Tumors [J].
Hope, Thomas A. ;
Bergsland, Emily K. ;
Bozkurt, Murat Fani ;
Graham, Michael ;
Heaney, Anthony P. ;
Herrmann, Ken ;
Howe, James R. ;
Kulke, Matthew H. ;
Kunz, Pamela L. ;
Mailman, Josh ;
May, Lawrence ;
Metz, David C. ;
Millo, Corina ;
O'Dorisio, Sue ;
Reidy-Lagunes, Diane L. ;
Soulen, Michael C. ;
Strosberg, Jonathan R. .
JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (01) :66-74
[8]   Imaging of myocardial inflammation with somatostatin receptor based PET/CT - A comparison to cardiac MRI [J].
Lapa, Constantin ;
Reiter, Theresa ;
Li, Xiang ;
Werner, Rudolf A. ;
Samnick, Samuel ;
Jahns, Roland ;
Buck, Andreas K. ;
Ertl, Georg ;
Bauer, Wolfgang R. .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 194 :44-49
[9]   Spectrum of 68Ga-DOTA TATE Uptake in Patients With Neuroendocrine Tumors [J].
Moradi, Farshad ;
Jamali, Mehran ;
Barkhodari, Amir ;
Schneider, Bernadette ;
Chin, Frederick ;
Quon, Andrew ;
Mittra, Erik S. ;
Iagaru, Andrei .
CLINICAL NUCLEAR MEDICINE, 2016, 41 (06) :E281-E287
[10]  
Pauwels E, 2018, AM J NUCL MED MOLEC, V8, P311